Cargando…
Therapeutic Potential of Polyphenols in Cardiac Fibrosis
Cardiac fibrosis, in response to injury and stress, is central to a broad constellation of cardiovascular diseases. Fibrosis decreases myocardial wall compliance due to extracellular matrix (ECM) accumulation, leading to impaired systolic and diastolic function and causing arrhythmogenesis. Although...
Autores principales: | Zhang, Ning, Wei, Wen-Ying, Li, Ling-Li, Hu, Can, Tang, Qi-Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818417/ https://www.ncbi.nlm.nih.gov/pubmed/29497382 http://dx.doi.org/10.3389/fphar.2018.00122 |
Ejemplares similares
-
Function and therapeutic potential of transient receptor potential ankyrin 1 in fibrosis
por: Wei, Yicheng, et al.
Publicado: (2022) -
Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
por: Piccialli, Ilaria, et al.
Publicado: (2022) -
Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?
por: Vestri, Ambra, et al.
Publicado: (2017) -
Geniposide Alleviates Isoproterenol-Induced Cardiac Fibrosis Partially via SIRT1 Activation in vivo and in vitro
por: Li, Ning, et al.
Publicado: (2018) -
Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis
por: Qin, Rui, et al.
Publicado: (2022)